Reprints:Snakebite and antivenoms in the Asia-Pacific: wokabaut wantaim, raka hebou ("walking together")

Cheng, Allen C; Winkel, Kenneth D

Topics

Social determinants of health

Poisoning

Although responsibility for health is national, the means to fulfil that responsibility are increasingly global.

Correspondence:

1.
Winkel KD. Strychine, ammonia and gunpowder for snake bite — theend of an era. Med J Aust 2001; 174: 607.
2.
Lalloo DG, Trevett AJ, Saweri A, et al. The epidemiology of snakebite in the Central Province and National Capital District, Papua NewGuinea. Trans R Soc Trop Med Hyg 1995; 89: 178-182.
3.
Warrell DA, Lalloo DG. Snake bite and its treatment in Papua NewGuinea. In: O'Shea M, editor. A guide to the snakes of Papua New Guinea.Madang, Papua New Guinea: Christensen Research Institute, 1996.
4.
Gajdusek DC. Urgent opportunistic observations: the study ofchanging, transient and disappearing phenomena of interest indisrupted primitive human communities. In: Ciba FoundationSymposium 49 (new series), editors. Health and diseases in tribalsocieties. Amsterdam: Elsevier, 1977.
5.
Trevett AJ, Lalloo DG, Nwokolo NC, et al. Venom detection kits in themanagement of snakebite in Central Province, Papua New Guinea.Toxicon 1995; 33: 703-705.
6.
Dyke T. In the tail of the taipan. A personal view of snakebite andserum sickness. Med J Aust 1995; 163: 614-615.
7.
Oakley J. Managing death adder bite with prolonged pressurebandaging. In: Handbook, Millennium 2000, the 36th PNG MedicalSociety Symposium. Port Moresby, Papua New Guinea: PNG MedicalSociety, 2000: 24.
8.
Calmette A. Propriétés du sérum des animaux immunisés contre levenin des serpents; thérapeutique de l'envenimation. C rhebd Seanc Acad Sci Paris 1894; 118: 720-722.
9.
Chippaux J-P. Snake bites: appraisal of the global situation.Bull World Health Organ 1998; 76: 515-524.
10.
WHO/SEARO guidelines for the clinical management of snake bitesin the Southeast Asian region. Southeast Asian J Trop Med PublicHealth 1999; 30 (Suppl 1): 1-85.
11.
Calmette A. étude éxperimentale du venin de Najatripudians or cobra capel. Ann l'Institute Pasteur1892; 6: 160-183.
12.
Cheng AC, Winkel KD. Call for global snakebite control andprocurement funding [letter]. Lancet 2001; 357:1132.
13.
Theakston RD, Warrell DA. Crisis in snake antivenom supply forAfrica [letter]. Lancet 2000; 356: 2104.
14.
McNamee D. Tackling venomous snake bites worldwide [news].Lancet 2001; 357: 1680.
15.
Currie B, Vince J, Naraqi S. Snake bite in Papua New Guinea. PNGMed J 1988; 31: 195-198.
16.
Currie B. Medicine in tropical Australia: the quality and price ofsnake antivenoms [letter]. Med J Aust 1993; 159: 284.
17.
Nossal GJV. Awakening the global conscience: Who will benefitfrom new vaccines in the 21st century? Immunol Cell Biol 1997;75: 584-586.
18.
Mahoney RT, Ramachandran S, Xu Z-Y. The introduction of newvaccines into developing countries II. Vaccine financing.Vaccine 2000; 18: 2625-2635.
19.
Jamison DT, Frenk J, Knaul F. International collective action inhealth: objectives, functions and rationale. Lancet 1998;351: 514-517.
20.
Muraskin WA. The politics of international health. Albany: StateUniversity of New York, 1998.
21.
Scholtz M. WHO's role in ensuring access to essential drugs.WHO Drug Infor 1999; 13: 217-220.
22.
Freeman P. The PAHO revolving fund: history, operations andcontribution to speeding vaccine introductions. Geneva:Children's Vaccine Initiative, 1999.
23.
Essential drugs: WHO Model list, 11th revision. WHO DrugInfor 1999; 13: 245-258.
24.
Sutherland SK. The sale of Commonwealth Serum Laboratories:wither antivenom research? Med J Aust 1992; 157: 731-732.
25.
Cheng AC, Ratcliff A, Adhikari P. Snake anti-venom in Papua NewGuinea. Fellowship Affairs 2000; 19: 26.
26.
Sutherland SK. Medicine in tropical Australia: the quality andprice of snake antivenoms. Med J Aust 1993; 159: 284.
27.
Galli R. The antivenin is safe, but its future is uncertain.West J Med 2001; 175: 91-92.
28.
Temu P. Health Secretary's message to the 2000 medical symposium.In: Handbook, Millennium 2000, the 36th PNG Medical SocietySymposium. Port Moresby, Papua New Guinea: PNG Medical Society,2000: 6-9.
29.
White J, editor. Clinical toxinology short course. 2001handbook. Adelaide: University of Adelaide Faculty of HealthSciences, 2001.
30.
AusAID. Papua New Guinea program profiles, 1999-2000. Canberra:Australian Agency for International Development, 2001.
31.
Einternz EM. International aid and medical practice in theless-developed world: doing it right. Lancet 2001; 357:1524-1525.

Online responses are no longer available. Please refer to our instructions for authors page for more information.